The guidelines for treating the sexually transmitted bacteria, gonorrhea, have been revised by U.S. health authorities due to the little option to fight resistant strains of gonorrhea.
The Centers for Disease Control and Prevention now recommends that the injectable antibiotic Rocephin be the first-line treatment for this sexually transmitted disease.
In 2007, the CDC recommended abandoning fluoroquinolones as a first-line treatment, thus leaving cephalosporins, which include Suprax and Rocephin, as the only class of antibiotics available to effectively combat gonorrhea.
The medical experts say that strains of gonorrhea that are resistant to the antibiotic, Suprax have increased globally.
Doctors say Rocephin should be used in combination with one of two oral antibiotics: azithromycin or doxycycline.
Although rates of gonorrhea are at historic lows, the CDC reports it is still the second most commonly recorded infection with more than 700,000 new U.S. cases annually.